$JNJ 4/A SEC Filings

Filed On	Filing
08 Jan 2026	Form 4/A: Johnson & Johnson, 10% owner and 1 other · Cvrx, Inc Sold 16,000 shares ($160K) · Sold 6,337 shares ($63.6K)
31 Oct 2024	Form 4/A: Reed John C, EVP, Innovative Medicine, R&D Received 25,255 shares by exercise or conversion · Gave up 10,984 shares to cover exercise price or tax ($1.59M)
03 Feb 2015	Form 4/A: Johnson & Johnson, 10% owner and 1 other · Neurogene Inc. Received 1,392,094 shares by conversion · Bought 272,727 shares ($3M)
08 Aug 2013	Form 4/A: Ullmann Michael H, VP, General Counsel Received 20,650 shares by exercise or conversion ($1.11M)
01 Feb 2013	Form 4/A: Coleman Mary Sue, Director Sold 7,600 shares ($526K)
18 Dec 2012	Form 4/A: Coleman Mary Sue, Director Holds 21,952 shares of Common Stock
12 Sep 2012	Form 4/A: Weldon William C, Director Holds 407,364 shares of Common Stock
10 May 2011	Form 4/A: Gorsky Alex, Member, Executive Committee Gave up 29,166 shares to cover exercise price or tax ($1.93M)
14 Sep 2009	Form 4/A: Casey Donald M Jr., Member, Executive Committee Received 13,800 shares by exercise or conversion ($581K) · Gave up 10,241 shares to cover exercise price or tax ($581K)
27 Aug 2009	Form 4/A: Goggins Colleen A, Member, Executive Committee Gave up 1,238 shares to cover exercise price or tax ($88.3K)
04 Jun 2004	Form 4/A: Johnson & Johnson, 10% owner and 3 others · BARRIER THERAPEUTICS INC Received 4,448,076 shares by conversion
28 May 2004	Form 4/A: Johnson & Johnson, 10% owner and 1 other · IMMUNICON CORP Received 1,753,236 shares by conversion

Comments